First-in-Class Dual Hybrid Carbonic Anhydrase Inhibitors and Transient Receptor Potential Vanilloid 1 Agonists Revert Oxaliplatin-Induced Neuropathy
Journal of Medicinal Chemistry · 2023
DOI: 10.1021/acs.jmedchem.2c01911 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2023. Verfasst von Andrea Angeli und 9 weiteren Autor:innen. Beteiligte Einrichtung: NEUROFARBA Department, Sezione di Scienze Farmaceutiche, University of Florence, via Ugo Schiff 6, 50019 Sesto Fiorentino, Florence, Italy. Hauptthemen laut MEDLINE: Carbonic Anhydrases, Antineoplastic Agents. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Here, we report for the first time a series of compounds potentially useful for the management of oxaliplatin-induced neuropathy (OINP) able to modulate the human Carbonic Anhydrases (hCAs) as well as the Transient Receptor Potential Vanilloid 1 (TRPV1). All compounds showed effective in vitro inhibition activity toward the main hCAs involved in such a pathology, whereas selected items reported moderate agonism of TRPV1. X-ray crystallographic experiments assessed the binding modes of the two enantiomers (R)-37a and (S)-37b within the hCA II cleft. Although the tails assumed diverse orientations, no appreciable effects were observed for their hCA II affinity. Similarly, the activity of (R)-39a and (S)-39b on TRPV1 was not influenced by the stereocenters. In vivo evaluation of the most promising derivatives (R)-12a, (R)-37a, and the two enantiomers (R)-39a, (S)-39b revealed antihypersensitivity effects in a mouse model of OINP with potent and persistent effect up to 75 min after administration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- NEUROFARBA Department, Sezione di Scienze Farmaceutiche, University of Florence, via Ugo Schiff 6, 50019 Sesto Fiorentino, Florence, Italy.
- Pharmacology and Toxicology Section, Department of Neuroscience, Psychology, Drug Research and Child Health (NEUROFARBA), University of Florence, viale Gaetano Pieraccini 6, 50139 Firenze, Florence, Italy.
- Department of Chemistry ″Ugo Schiff″, University of Florence, via della Lastruccia 3-13, I-50019 Sesto Fiorentino, Italy.
- Dipartimento Di Scienze del Farmaco, Università Degli Studi del Piemonte Orientale, 28100 Novara, Italy.
- Instituto de Investigación, Desarrollo e Innovación en Biotecnología Sanitaria de Elche (IDiBE), Universitas Miguel Hernández, 03202 Elche, Spain.
ORCID-Profile: Andrea Angeli, Fabrizio Carta, Marta Ferraroni, Tracey Pirali, Claudiu T Supuran
Zitieren
APA
Angeli, A., Micheli, L., Carta, F., Ferraroni, M., Pirali, T., Fernandez Carvajal, A., Ferrer Montiel, A., Di Cesare Mannelli, L., Ghelardini, C., & Supuran, C. T. (2023). First-in-Class Dual Hybrid Carbonic Anhydrase Inhibitors and Transient Receptor Potential Vanilloid 1 Agonists Revert Oxaliplatin-Induced Neuropathy. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.2c01911
Vancouver
Angeli A, Micheli L, Carta F, Ferraroni M, Pirali T, Fernandez Carvajal A, et al. First-in-Class Dual Hybrid Carbonic Anhydrase Inhibitors and Transient Receptor Potential Vanilloid 1 Agonists Revert Oxaliplatin-Induced Neuropathy. Journal of Medicinal Chemistry. 2023. doi:10.1021/acs.jmedchem.2c01911
BibTeX
@article{Angeli2023,
author = {Angeli, Andrea and Micheli, Laura and Carta, Fabrizio and Ferraroni, Marta and Pirali, Tracey and Fernandez Carvajal, Asia and Ferrer Montiel, Antonio and Di Cesare Mannelli, Lorenzo and Ghelardini, Carla and Supuran, Claudiu T},
title = {First-in-Class Dual Hybrid Carbonic Anhydrase Inhibitors and Transient Receptor Potential Vanilloid 1 Agonists Revert Oxaliplatin-Induced Neuropathy},
journal = {Journal of Medicinal Chemistry},
year = {2023},
doi = {10.1021/acs.jmedchem.2c01911}
}
EUVIMED